Eui Y. Kim

Busan, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Inflammatory biomarkers predict outcomes of patients with radioactive iodine refractory thyroid cancer treated with sorafenib.

Inflammatory biomarkers predict outcomes of patients with radioactive iodine refractory thyroid cancer treated with sorafenib.

Journal: Endocrine

Published: January 27, 2023

Lenvatinib Compared with Sorafenib as a First-Line Treatment for Radioactive Iodine-Refractory, Progressive, Differentiated Thyroid Carcinoma: Real-World Outcomes in a Multicenter Retrospective Cohort Study.

Lenvatinib Compared with Sorafenib as a First-Line Treatment for Radioactive Iodine-Refractory, Progressive, Differentiated Thyroid Carcinoma: Real-World Outcomes in a Multicenter Retrospective Cohort Study.

Journal: Thyroid : official journal of the American Thyroid Association

Published: April 21, 2022

Purification and characterization of a novel acid-tolerant and heterodimeric β-glucosidase from pumpkin (Cucurbita moschata) seed.

Purification and characterization of a novel acid-tolerant and heterodimeric β-glucosidase from pumpkin (Cucurbita moschata) seed.

Journal: Journal of bioscience and bioengineering

Published: January 19, 2021

Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Candidate Biomarkers Associated with Survival: A Multicenter Study in Korea.

Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Candidate Biomarkers Associated with Survival: A Multicenter Study in Korea.

Journal: Thyroid : official journal of the American Thyroid Association

Published: January 08, 2020

Extended Real-World Observation of Patients Treated with Sorafenib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Impact of Lenvatinib Salvage Treatment: A Korean Multicenter Study.

Extended Real-World Observation of Patients Treated with Sorafenib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Impact of Lenvatinib Salvage Treatment: A Korean Multicenter Study.

Journal: Thyroid : official journal of the American Thyroid Association

Published: October 09, 2019

Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study.

Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study.

Journal: Thyroid : official journal of the American Thyroid Association

Published: January 20, 2018

Usefulness of NRAS codon 61 mutation analysis and core needle biopsy for the diagnosis of thyroid nodules previously diagnosed as atypia of undetermined significance.

Usefulness of NRAS codon 61 mutation analysis and core needle biopsy for the diagnosis of thyroid nodules previously diagnosed as atypia of undetermined significance.

Journal: Endocrine

Published: June 17, 2015

Metformin Is Associated with a Favorable Outcome in Diabetic Patients with Cervical Lymph Node Metastasis of Differentiated Thyroid Cancer.

Metformin Is Associated with a Favorable Outcome in Diabetic Patients with Cervical Lymph Node Metastasis of Differentiated Thyroid Cancer.

Journal: European thyroid journal

Published: February 26, 2015

Association between thyroid autoimmunity and Helicobacter pylori infection.

Association between thyroid autoimmunity and Helicobacter pylori infection.

Journal: The Korean journal of internal medicine

Published: December 01, 2014

Selective embolization for hypervascular metastasis from differentiated thyroid cancer: a case series.

Selective embolization for hypervascular metastasis from differentiated thyroid cancer: a case series.

Journal: Journal of medical case reports

Published: May 13, 2014

Long-term consequence of elevated thyroglobulin in differentiated thyroid cancer.

Long-term consequence of elevated thyroglobulin in differentiated thyroid cancer.

Journal: Thyroid : official journal of the American Thyroid Association

Published: September 15, 2012

Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatment.

Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatment.

Journal: Thyroid : official journal of the American Thyroid Association

Published: July 12, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026